Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions express strong support and high interest in the research, with examples like mentions of the publication in NEJM, awards received by researchers, and statements like 'major breakthrough' and 'promising results.' The tone underscores excitement about the clinical and societal impact, with references to detailed study outcomes and future prospects.
Most discussions support the findings and potential of omalizumab for food allergies, reflecting broad agreement on its effectiveness.
Posts show high curiosity and enthusiasm, with many sharing excitement about the breakthrough and mentioning specific studies and awards.
Many discussions delve into technical details, cite research outcomes, and share linked studies, indicating deep involvement.
The widespread sharing of results, references to prestigious publications, and mention of clinical implications suggest the discussions highlight a significant potential impact.
Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multiple Food Allergies — Food Avoidance or Pharmacologic Treatment? https://t.co/rvbUDVzryS #ClinicalMedicine https://t.co/CwEhz23Lbm
Omalizumab for the Treatment of Multiple Food Allergies https://t.co/8bngvCyYH0 https://t.co/DHRuL6nOXT
Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multiple Food Allergies — Food Avoidance or Pharmacologic Treatment? https://t.co/rvbUDVzryS https://t.co/FQoz4jAvRS
هيئة الغذاء والدواء @US_FDA اعتمدت دواء
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/fJwq3HtDOz
Welcome to a special 2-part series reviewing the FDA approval of omalizumab for food allergy. The first part discusses evidence from the OUTMATCH study showing effectiveness in allowing safe consumption of allergenic…
The study OutMatch evaluated omalizumab's efficacy and safety in patients with multiple food allergies, showing significant improvements in allergen tolerance after 16 weeks, especially for peanut, with an acceptable…
Join us as we explore the FDA approval of omalizumab for treating food allergies. This medication significantly reduces severe reactions like anaphylaxis in both adults and children, offering new hope for safer allergy…
This video discusses a clinical trial testing omalizumab, an anti-IgE antibody, for treating multiple food allergies in individuals aged 1 to 55. The study found that 67% of patients on omalizumab successfully consumed…
This clinical trial assesses the safety and efficacy of omalizumab, an anti-IgE antibody, in enabling individuals aged 1 to 55 to safely consume allergenic foods like peanuts, cashew, milk, and egg, showing promising…
This week has some good news and some bad news. Highlights include a peer review process error, positive effects of Hiroshima's nuclear bombing, and recent scientific findings like the potential of omalizumab to treat…
This video discusses the latest research on using omalizumab to treat multiple food allergies, highlighting its potential to enable safe consumption of allergens like peanuts, with focus on clinical trial outcomes and…
Wood RA, Togias A, Sicherer SH, et al. Omalizumab for the Treatment of Multiple Food Allergies. N Engl J Med. 2024;390(10):889-899. doi:10.1056/NEJMoa2312382 https://t.co/leAirHjV0T
Our latest research contributed to a major breakthrough—earning a spot in National Geographic’s Top 7 Medical Breakthroughs of 2024!
Omalizumab for the Treatment of Multiple Food Allergies #allergy #immunology www.nejm.org/doi/full/10....
Congrats to Robert Wood, MD, of @ictrjhu on winning the Distinguished Clinical Research Achievement Award this past week at TS2025! Check out his work researching the usage of omalizumab on food allergies below. https://t.co/flpPB3W24q https://t.co/8FX0ppvO5b
Drew Bird, M.D., and Christopher Parrish, M.D., were members of a clinical trial on the use of omalizumab to reduce food allergy reactions that the @NEJM recently featured in their Notable Articles of 2024 collection. Read more: https://t.co/yAitQANQSK @UTSWMedCenter @childrens https://t.co/DbwBcAszm6
そばが食べられるようになるかもしれない医学論文だ https://t.co/f5Xu3DaULu
Omalizumab shows promise for multiple food allergies! A study with 105 participants aged 1-55 allergic to peanuts & 2+ others finds safety & efficacy. #FoodAllergyBreakthrough PMID:38407394, N Engl J Med 2024, @NEJM @Stanford https://t.co/YGRThs7K9w
RT @DrAkhilX: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/8bngvCyYH0 https://t.co/DHRuL6nOXT
2/14 Omalizumab for the Treatment of Multiple Food Allergies... https://t.co/XqXO97Z26Y
RT @DrAkhilX: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/8bngvCyYH0 https://t.co/DHRuL6nOXT
Omalizumab for the Treatment of Multiple Food Allergies 1 https://t.co/j98gJRelAy
RT @DrAkhilX: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/8bngvCyYH0 https://t.co/DHRuL6nOXT
RT @DrAkhilX: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/8bngvCyYH0 https://t.co/DHRuL6nOXT
RT @DrAkhilX: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/8bngvCyYH0 https://t.co/DHRuL6nOXT
Omalizumab for the Treatment of Multiple Food Allergies https://t.co/8bngvCyYH0 https://t.co/DHRuL6nOXT
RT @marcarrionUCM: @DiConCiencia Muy prometedores los resultados obtenidos con Omalizumab y más teniendo en cuenta que el estudio original…
@DiConCiencia Muy prometedores los resultados obtenidos con Omalizumab y más teniendo en cuenta que el estudio original https://t.co/gs7qG1bjaY está publicado en The New England Journal of Medicine (NEJM), una de las revistas médicas más prestigiosas.
Omalizumab for the Treatment of Multiple Food Allergies https://t.co/CEmSbIGLLg
Omalizumabが食物アレルギーの治療に使えるのか。もうOITだけが治療法！とは書けないのねえ。https://t.co/bFpbvCvR0g
the big news of 2024 for #foodallergy @foodallergy https://t.co/rXP7P7NqND https://t.co/juL376wsXe
RT @salonium: The trial results, published earlier this year, are also quite impressive: https://t.co/IbLO8hx1jt https://t.co/0ukjISMMqD
RT @salonium: The trial results, published earlier this year, are also quite impressive: https://t.co/IbLO8hx1jt https://t.co/0ukjISMMqD
The trial results, published earlier this year, are also quite impressive: https://t.co/IbLO8hx1jt https://t.co/0ukjISMMqD
抗IgE抗体の投与による食物アレルギーの治療の可能性/Omalizumab for the Treatment of Multiple Food Allergies | New England Journal of Medicine https://t.co/J1vta223Hc
Omalizumab for the Treatment of Multiple Food Allergies | New England Journal of Medicine https://t.co/sYJCFmIJAJ Interesting! Coming to uk......??
Omalizumab for the Treatment of Multiple Food Allergies | NEJM - https://t.co/pmrNj8VNiI: Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/pmrNj8VNiI https://t.co/z0Hju97QMS
@SALightPress Just wanted to clarify that Valencia peanuts can still cause a reaction for people with peanut allergies. Valencia peanuts are good for people with mold allergies. New treatments to help people with more severe allergies to peanuts are on the horizon: https://t.co/BxnuUyhxgT
Omalizumab for the Treatment of Multiple Food Allergies | New England Journal of Medicine ゾレアは複数抗原の食べ物アレルギーにも効くかもよ https://t.co/WUL35D7YYh
オマリズマブ（ゾレア®）による複数の食物アレルギーの治療 https://t.co/bVNZ5J62dw RCT P:ピーナッツアレルギーと、 その他 2 つ以上の食物アレルギーを有する 1～55 歳 I:オマリズマブ皮下投与 C:プラセボ O:ピーナッツタンパクを単回600mg以上を症状なく摂取可能 →オマリズマブの効果アリ #JCメモ
食物アレルギーを有する患者に対して，抗体IgE抗体であるオマリズマブの投与が効果的かつ安全性であることが示された。ピーナッツおよび他の食物にアレルギーのある人を対象。 #ゾレア #食物アレルギー #ピーナツアレルギー #オマリズマブ https://t.co/39WWeEHyYf
RT @shirakabapollen: このところ、ちらちらと言及が目につく論文。 オマリズマブ…ゾレアの論文だね！ IgEに対する抗体だから、そりゃ使用中はアレルギー反応が出にくくなるんだろうね！ ただ、これが食物アレルギーの 『治療』 になり得るかどうかは、まだ今後の…
このところ、ちらちらと言及が目につく論文。 オマリズマブ…ゾレアの論文だね！ IgEに対する抗体だから、そりゃ使用中はアレルギー反応が出にくくなるんだろうね！ ただ、これが食物アレルギーの 『治療』 になり得るかどうかは、まだ今後のstudy次第だよ！ https://t.co/bHhkEcWTUV
複数食物アレルギー患者に対し、オマリズマブは複数の食物抗原の反応閾値を上昇させた。1歳からの治療効果が確認され、偶発的暴露による典型的な症状を防ぐのに十分な用量を多くの参加者が摂取可能になった。 https://t.co/7RFEORBio9 https://t.co/Q47xfUBlzy
ゾレアが食物アレルギーの反応を大幅に軽減することが明らかとなり、FDAは食物アレルギーにも適応拡大したようです 誤食によるリスクを軽減する使い方は想定できそうですが、薬価が高すぎるのが最大の難点 それでも食物アレルギー治療の素晴らしい進歩だと思います https://t.co/4TR9g0S8UN
Zdroj (2/2): Dantzer, J., Mudd, K., … Chinthrajah, R. S. (2024). Omalizumab for the Treatment of Multiple Food Allergies. The New England journal of medicine, 390(10), 889–899. https://t.co/vULjrnyAk5
複数の食物アレルギーを持つ患者にオマリズマブを投与したところ、ピーナッツなどのアレルゲンに対する反応閾値が上昇した。1歳以上の小児・青年期の患者で、プラセボより有意に優れていた。注射部位反応以外の安全性に問題はなく、有望な治療法となる可能性が示された。DOI: 10.1056/NEJMoa2312382
Outcomes of Using Omalizumab for the Treatment of Multiple Food Allergies | PracticeUpdate https://t.co/3Ehz7zH7ft
RT @NEJM: 2. Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p #Immunology https://t.co/2gf…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
@ShaanVP Dupixent and if that doesn’t work Xolair https://t.co/Ss4BVAllOX
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/TY1Iw0ZHWG
https://t.co/OWdGcM84RW
Trending on PubMed: Omalizumab for the Treatment of Multiple Food Allergies. https://t.co/IpaURixh71
RT @ATSPeds: Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/i03Y00kMAT TA: @MSUPedsPulm #pedspulm
Omalizumab, a monoclonal anti-IgE antibody, can reduce allergic reactions when small amounts of allergy-triggering foods are accidentally ingested, according to a @StanfordMed study. Read the findings in @NEJM: https://t.co/T5GS3DEXQj.
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/i03Y00kMAT TA: @MSUPedsPulm #pedspulm
https://t.co/N1pZRiNS9m
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
RT @NEJM: In this trial involving 180 persons with food allergies, omalizumab was effective in increasing the reaction threshold for peanut…
@nitrotake これこれ と思ったけどデュピルマブじゃなかったわ https://t.co/FeeWO5D5o3
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/JQwyw59gWV
A new treatment for Peanut allergy #journalclub https://t.co/Y89H5lNC0f
RT @NEJM: 2. Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p #Immunology https://t.co/2gf…
RT @NEJM: 2. Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p #Immunology https://t.co/2gf…
2. Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p #Immunology https://t.co/2gfGQvAMM7
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/j6bqmOCb2d
RT @EARL_med_tw:
【論文紹介：複数食物アレルギーの治療にオマリズマブの使用が有効か】 ・複数の食物アレルギーを有する1歳の幼児において、16週間のオマリズマブ投与は、ピーナッツおよび他の一般的な食物アレルゲンに対する反応閾値の上昇においてプラセボより優れていた #小児 #アレルギー https://t.co/PxZ58NmCiX
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/YZn1KMQNSC
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/8Q01axNwZo
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multiple Food Allergies — Food Avoidance or Pharmacologic Treatment? https://t.co/rvbUDVzryS #ClinicalMedicine https://t.co/CwEhz23Lbm
Omalizumab for the Treatment of Multiple Food Allergies https://t.co/m53ygoa7sh?
Antibody reduces allergic reactions to multiple foods in NIH clinical trial https://t.co/Ju62zUAeiy NIH 2/25/2024 - Omalizumab for the Treatment of Multiple Food Allergies Robert A. Wood, M.D. et al. https://t.co/VY07voUIhW NEJM 2/25/2024
Omalizumab for the Treatment of Multiple Food Allergies https://t.co/Hg3d0LTOMO
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/3aqAA3x4U9
【RCT】ピーナッツおよび2つ以上の試験で指定した食物にアレルギーのある1〜55歳の人へのオマリズマブ投与は、プラセボ投与と比較して、用量を制限する症状なしに1回600mg以上のピーナッツタンパクを経口摂取に成功した人の数を増加させた。 #ペ読 https://t.co/uOHWrMRROy
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
The study in "NEJM" the above "Scientific American" article is based upon, & links to: “Omalizumab for the Treatment of Multiple Food Allergies” https://t.co/2JNwKzr6Th
RT @DrJeanneM: Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/LVAGeFOdLT
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/vBkEz6veEo
RT @sotoretes: Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/fJwq3HtDOz
Omalizumab for the Treatment of Multiple Food Allergies https://t.co/pAZlcMEvpO #allergy
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/XzPZBk2b10
#Medicina #Terapeutica #Farmacología #Inmunología #Alergología #Omalizumab Omalizumab for the Treatment of Multiple Food Allergies. Robert A. Wood, Alkis Togias, Scott H. Sicherer, Wayne G. Shreffler et al. February 25, 2024 DOI: 10.1056/NEJMoa2312382 https://t.co/ty7cSo3zYr
RT @DrJeanneM: Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/LVAGeFOdLT
RT @sotoretes: Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/fJwq3HtDOz
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/uxGjd69gQW
RT @DrJeanneM: Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/LVAGeFOdLT
RT @DrJeanneM: Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/LVAGeFOdLT
RT @sotoretes: Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/fJwq3HtDOz
RT @sotoretes: Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/fJwq3HtDOz
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/fJwq3HtDOz
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/sR6osWJg2T #FoodAllergies
RT @DrJeanneM: Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/LVAGeFOdLT
RT @DrJeanneM: Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/LVAGeFOdLT
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/LVAGeFOdLT
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
RT @YAYshamsaldeen: هيئة الغذاء والدواء @US_FDA اعتمدت دواء
RT @YAYshamsaldeen: هيئة الغذاء والدواء @US_FDA اعتمدت دواء
RT @YAYshamsaldeen: هيئة الغذاء والدواء @US_FDA اعتمدت دواء
RT @YAYshamsaldeen: هيئة الغذاء والدواء @US_FDA اعتمدت دواء
RT @YAYshamsaldeen: هيئة الغذاء والدواء @US_FDA اعتمدت دواء
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
RT @YAYshamsaldeen: هيئة الغذاء والدواء @US_FDA اعتمدت دواء
RT @YAYshamsaldeen: هيئة الغذاء والدواء @US_FDA اعتمدت دواء
هيئة الغذاء والدواء @US_FDA اعتمدت دواء
Omalizumab for the treatment of multiple food allergies https://t.co/EC9JZmwqN1
Omalizumab for the Treatment of Multiple Food Allergies #science #publication #research #publications https://t.co/5s0nobSzg1
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/SD5fQAhMTW #Food #FoodAllergy #Peanuts #PeanutAllergy #Immunotherapy #science #research #medicine
The paper in "NEJM" the above "Nature" article is based upon, & links to: “Omalizumab for the Treatment of Multiple Food Allergies” 2/2 https://t.co/H3ErRcNQIj
RT @NEJM: Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multip…
Original Article: Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FKbAqMmw6p Editorial: Options for Multiple Food Allergies — Food Avoidance or Pharmacologic Treatment? https://t.co/rvbUDVzryS https://t.co/FQoz4jAvRS
Omalizumab for the Treatment of Multiple Food Allergies | NEJM decreased risk of dangerous reactions after exposure to accidental exposures of allergens https://t.co/xbGZqKfuQQ
【食物アレルギーにもオマリズマブ有効】アメリカ国立衛生研究所などの研究者は、モノクローナル抗体製剤オマリズマブが複数の食物アレルギーにおける危険な反応を軽減させることを臨床試験で確認しました
ΗΠΑ: Εγκρίθηκε φάρμακο για τροφικές αλλεργίες https://t.co/JGMscDOvwi https://t.co/vhhMKi11MG
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/xGqWK3YlJY
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/hWA5UeWCtq
Allergy is a massive market This is material $RHHBY Xolair (omalizumab) Omalizumab for the Treatment of Multiple Food Allergies https://t.co/FE2pAGR2FC
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/yUzPAP99u6
RT @GlobalPHObserv: Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/jQ8k157EMD
RT @ProfIsAlMadany: دراسة في مجلة أمريكية تفيد بأن الدواء"Omalizumab"الذي يباع تجارياً تحت إسم"Xolair" والذي يستخدم لعلاج حالات الربو، مفيد…
RT @GlobalPHObserv: Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/jQ8k157EMD
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/jQ8k157EMD
Drug limits dangerous reactions to #allergy-triggering foods: A drug that binds to allergy-causing #antibodies can protect #children from dangerous reactions to accidentally eating allergy-triggering foods, a new study found. https://t.co/oWclRrlJtp https://t.co/4ZrhpDlHrO
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/pUt6LA49ca
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/Zc2nGOBlEp
RT @ProfIsAlMadany: دراسة في مجلة أمريكية تفيد بأن الدواء"Omalizumab"الذي يباع تجارياً تحت إسم"Xolair" والذي يستخدم لعلاج حالات الربو، مفيد…
دراسة في مجلة أمريكية تفيد بأن الدواء"Omalizumab"الذي يباع تجارياً تحت إسم"Xolair" والذي يستخدم لعلاج حالات الربو، مفيد جداً لعلاج المرضى الذين يعانون من الحساسية من بعض أنواع الطعام. Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/yY0bTu5qtp
Omalizumab for the Treatment of Multiple Food Allergies | NEJM https://t.co/APQ2OTZmxz
New for me- journal publishing the results of the study as I am listening to results being presented at the #AAAAI24 -You can read @NEJM -Omalizumab for the Treatment of Multiple Food Allergies | https://t.co/DUVB7cEu2M